May 2010 - Volume 16 - Issue 5
pp: 721-902
Subscribe to eTOC

Effect of EP4 agonist (ONO‐4819CD) for patients with mild to moderate ulcerative colitis refractory to 5‐aminosalicylates: A randomized phase II, placebo‐controlled trial

Nakase, Hiroshi; Fujiyama, Yoshihide; Oshitani, Nobuhide; More

Inflammatory Bowel Diseases . 16(5):731-733, May 2010.


Novel model of TH2‐polarized chronic ileitis: The SAMP1 mouse

McNamee, Eoin N.; Wermers, Joshua D.; Masterson, Joanne C.; More

Inflammatory Bowel Diseases . 16(5):743-752, May 2010.

Cdcs1 a major colitis susceptibility locus in mice; Subcongenic analysis reveals genetic complexity

Bleich, Andre; Büchler, Gwen; Beckwith, Jason; More

Inflammatory Bowel Diseases . 16(5):765-775, May 2010.

Nutriose, a prebiotic low‐digestible carbohydrate, stimulates gut mucosal immunity and prevents TNBS‐induced colitis in piglets

Pouillart, Philippe R.; Dépeint, Flore; Abdelnour, Afif; More

Inflammatory Bowel Diseases . 16(5):783-794, May 2010.



Mapping of inflammatory bowel disease in northern France: Spatial variations and relation to affluence

Declercq, Christophe; Gower-Rousseau, Corinne; Vernier-Massouille, Gwénola; More

Inflammatory Bowel Diseases . 16(5):807-812, May 2010.

Fine‐scale geographic variations of inflammatory bowel disease in France: Correlation with socioeconomic and house equipment variables

Nerich, Virginie; Monnet, Elisabeth; Weill, Alain; More

Inflammatory Bowel Diseases . 16(5):813-821, May 2010.

Ulcerative colitis in a Southern European country: A national perspective

Portela, Francisco; Magro, Fernando; Lago, Paula; More

Inflammatory Bowel Diseases . 16(5):822-829, May 2010.

Lipopolysaccharide exposure is linked to activation of the acute phase response and growth failure in pediatric Crohn's disease and murine colitis

Pasternak, Brad A.; D'Mello, Sharon; Jurickova, Ingrid I.; More

Inflammatory Bowel Diseases . 16(5):856-869, May 2010.